Peter Schirmacher

62.2k citations

681 papers · 36.7k indexed · 5 hit papers · h-index 86

Impact in

Hepatology top 0.02%
- Hepatocellular Carcinoma Treatment and Prognosis
Cancer Research top 0.05%
- Cancer Genomics and Diagnostics

Papers in

Hepatology 120
- Liver physiology and pathology 42
Cancer Research 151
- Cancer Genomics and Diagnostics 88

Co-authors: Josep M. Llovet Peter R. Galle Vincenzo Mazzaferro Valérie Vilgrain Alejandro Forner Jean‐Luc Raoul Fabio Piscaglia Kai Breuhahn
Journals: Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (35 papers)Hepatology (32 papers)Journal of Hepatology (21 papers)International Journal of Cancer (19 papers)Genes Chromosomes and Cancer (17 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Peter Schirmacher

659 papers receiving 36.2k citations

Hit Papers

5 papers align trajectories log scale

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines 2021 · 306 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Annals of Oncology
2019 Histopathology
2018 Journal of Hepatology
2018 Annals of Oncology
2012 Journal of Clinical Oncology

Peers

Countries citing papers authored by Peter Schirmacher

Since Specialization

Citations

This map shows the geographic impact of Peter Schirmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schirmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schirmacher more than expected).

Fields of papers citing papers by Peter Schirmacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schirmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schirmacher. The network helps show where Peter Schirmacher may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Schirmacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Schirmacher Line = papers co-authored together Peter Schirmacher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gene und Pathways: FGFR2‑Translokationen und Fusionsanalytik PubMed ·Olaf Neumann, Markus Ball, Ulrich Lehmann, Peter Schirmacher, Albrecht Stenzinger, Daniel Kazdal	2022	0
2	Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis Gut ·Benjamin Goeppert, Damian Stichel, Réka Tóth, Sarah Fritzsche, M. Loeffler, Anna Melissa Schlitter, Olaf Neumann, Yassen Assenov, Monika Vogel, Arianeb Mehrabi, Katrin Hoffmann, Bruno Köhler, Christoph Springfeld, Dieter Weichenhan, Christoph Plass, Iréne Esposito, Peter Schirmacher, Andreas von Deimling, Stéphanie Roessler	2021	33
3	YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis Cancer Research ·Stefan Thomann, Sofia M.E. Weiler, Simone Marquard, Fabian Rose, Claudia R. Ball, Marcell Tóth, Teng Wei, Carsten Sticht, Sarah Fritzsche, Stéphanie Roessler, Carolina De La Torre, Eduard Ryschich, Olga Ermakova, Carolin Mogler, Daniel Kazdal, Norbert Gretz, Hanno Glimm, Eugen Rempel, Peter Schirmacher, Kai Breuhahn	2020	37
4	Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of theNanoString nCountertechnology with targetedRNAsequencing Genes Chromosomes and Cancer ·Suranand B. Talla, Eugen Rempel, Volker Endris, Maximilian Jenzer, Michael Allgäuer, Constantin Schwab, Daniel Kazdal, Fabian Stögbauer, Anna‐Lena Volckmar, Ildikó Kocsmár, Olaf Neumann, Peter Schirmacher, Stefanie Zschäbitz, Stefan Duensing, Jan Budczies, Albrecht Stenzinger, Martina Kirchner	2020	9
5	The 2019 WHO classification of tumours of the digestive system Histopathology ·Irıs D. Nagtegaal, Robert D. Odze, David S. Klimstra, Valérie Paradis, Massimo Rugge, Peter Schirmacher, Kay Washington, Fátima Carneiro, Ian A. Cree, (unknown) Hit paper breakdown →	2019	2366
6	Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis International Journal of Cancer ·Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna‐Lena Volckmar, Martina Kirchner, Jonas Leichsenring, Amelie Lier, Moritz von Winterfeld, Roland Penzel, Petros Christopoulos, Michael Thomas, Stefan Fröhling, Peter Schirmacher, Jan Budczies, Albrecht Stenzinger	2018	117
7	An Inducible Hepatocellular Carcinoma Model for Preclinical Evaluation of Antiangiogenic Therapy in Adult Mice Cancer Research ·Anja Runge, Junhao Hu, Matthias Wieland, Jan-Philip Bergeest, Carolin Mogler, (unknown), Cyrill Géraud, Bernd Arnold, Karl Rohr, Dorde Komljenovic, Peter Schirmacher, Sergij Goerdt, Hellmut G. Augustin	2014	22
8	97. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. Der Pathologe ·Peter Schirmacher	2013	1
9	Targeting the BRAF V600E Mutation in Multiple Myeloma Cancer Discovery ·Mindaugas Andrulis, Nicola Lehners, David Capper, Roland Penzel, Christoph Heining, Jennifer Hüellein, Thorsten Zenz, Andreas von Deimling, Peter Schirmacher, Anthony D. Ho, Hartmut Goldschmidt, Kai Neben, Marc S. Raab	2013	171
10	Colorectal Cancer Risk Associated with Hormone Use Varies by Expression of Estrogen Receptor-β Cancer Research ·Anja Rudolph, Csaba Tóth, Michael Hoffmeister, Wilfried Roth, Esther Herpel, Peter Schirmacher, Hermann Brenner, Jenny Chang‐Claude	2013	44
11	The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival Journal of Clinical Oncology ·Arne Warth, Thomas Muley, Michael Meister, Albrecht Stenzinger, Michael Thomas, Peter Schirmacher, Philipp A. Schnabel, Jan Budczies, Hans Hoffmann, Wilko Weichert Hit paper breakdown →	2012	542
12	Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines Clinical Cancer Research ·Niels Halama, Monika Braun, Christoph Kahlert, Anna Spille, Christian Quack, Nuh N. Rahbari, Moritz Koch, Jürgen Weitz, Matthias Kloor, Inka Zoernig, Peter Schirmacher, Karsten Brand, Niels Grabe, Christine S. Falk	2011	232
13	Heat Shock Protein 90-Sheltered Overexpression of Insulin-Like Growth Factor 1 Receptor Contributes to Malignancy of Thymic Epithelial Tumors Clinical Cancer Research ·Marco Breinig, Philipp Mayer, Andreas Harjung, Benjamin Goeppert, Mona Malz, Roland Penzel, Olaf Neumann, Arndt Hartmann, Hendrik Dienemann, Giuseppe Giaccone, Peter Schirmacher, Michael Kern, Gabriela Chiosis, Ralf J. Rieker	2011	21
14	Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy Cancer Research ·Niels Halama, Sara Michel, Matthias Kloor, Inka Zoernig, Axel Benner, Anna Spille, Thora Pommerencke, Doeberitz Magnus von Knebel, Gunnar Folprecht, Birgit Luber, Nadine Feyen, Uwe M. Martens, Philipp Beckhove, Sacha Gnjatic, Peter Schirmacher, Esther Herpel, Juergen Weitz, Niels Grabe, Dirk Jaeger	2011	321
15	Both high and low maternal salt intake in pregnancy alter kidney development in the offspring American Journal of Physiology-Renal Physiology ·Nadezda Koleganova, Grzegorz Piecha, Eberhard Ritz, Luís Eduardo Becker, Annett Múller, Monika Weckbach, Jens Randel Nyengaard, Peter Schirmacher, Marie-Luise Groß-Weißmann	2011	69
16	Chronic Inflammatory IFN-γ Signaling Suppresses Hepatocarcinogenesis in Mice by Sensitizing Hepatocytes for Apoptosis Cancer Research ·Stefan Lüth, Jörg Schrader, S Zander, Antonella Carambia, Juliane Buchkremer, Samuel Huber, Kurt Reifenberg, Ken–ichi Yamamura, Peter Schirmacher, Ansgar W. Lohse, Johannes Herkel	2011	25
17	Danger Signaling Protein HMGB1 Induces a Distinct Form of Cell Death Accompanied by Formation of Giant Mitochondria Cancer Research ·Georg Gdynia, Martina Keith, Jürgen Kopitz, Marion Bergmann, Anne Fassl, Alexander N.R. Weber, Julie George, Tim Kees, Hans-Walter Zentgraf, Otmar D. Wiestler, Peter Schirmacher, Wilfried Roth	2010	44
18	Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer Clinical Cancer Research ·Stephan Macher‐Goeppinger, Sebastian Aulmann, Katrin E. Tagscherer, Nina Wagener, Axel Haferkamp, Roland Penzel, Antje Brauckhoff, Markus Hohenfellner, Jaromir Sykora, Henning Walczak, Bin Tean Teh, Frank Autschbach, Esther Herpel, Peter Schirmacher, Wilfried Roth	2009	56
19	Coordinated Expression of Stathmin Family Members by Far Upstream Sequence Element-Binding Protein-1 Increases Motility in Non–Small Cell Lung Cancer Cancer Research ·Stephan Singer, Mona Malz, Esther Herpel, Arne Warth, Michaela Bissinger, Martina Keith, Thomas Muley, Michael Meister, Hans Hoffmann, Roland Penzel, Georg Gdynia, Volker Ehemann, Philipp A. Schnabel, Ruprecht Kuner, Peter E. Huber, Peter Schirmacher, Kai Breuhahn	2009	83
20	Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis Proceedings of the National Academy of Sciences ·F. Thomas Wunderlich, Tom Luedde, Stephan Singer, Marc Schmidt‐Supprian, Julia Baumgartl, Peter Schirmacher, Manolis Pasparakis, Jens C. Brüning	2008	90

About Peter Schirmacher

Peter Schirmacher is a scholar working on Hepatology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 681 papers that have together received 36.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (88 papers), Liver Disease Diagnosis and Treatment (67 papers), Lung Cancer Treatments and Mutations (62 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (54 papers), Pancreatic and Hepatic Oncology Research (49 papers), Liver physiology and pathology (42 papers), Cancer Immunotherapy and Biomarkers (37 papers) and Hepatitis B Virus Studies (36 papers). The work is most often cited by research in Hepatology (10.6k citations), Cancer Research (7.6k citations), Oncology (11.6k citations), Epidemiology (9.2k citations) and Pulmonary and Respiratory Medicine (6.7k citations). Peter Schirmacher has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Josep M. Llovet, Peter R. Galle, Vincenzo Mazzaferro, Valérie Vilgrain, Alejandro Forner, Jean‐Luc Raoul, Fabio Piscaglia, Kai Breuhahn, Thomas Longerich and Arne Warth. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Hepatology, Journal of Hepatology, International Journal of Cancer and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact